Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,433 | 37,142 | 33,407 | 64,459 | 48,875 |
| Marketable Securities | 275,043 | 311,605 | 297,068 | 255,453 | 301,614 |
| Receivables | 36,544 | 36,483 | 25,522 | 28,909 | 24,089 |
| Inventories | 39,228 | 38,714 | 38,853 | 39,761 | 39,705 |
| Other current assets | 1,129 | 2,700 | 6,976 | 1,995 | 1,031 |
| TOTAL | $446,596 | $440,459 | $409,666 | $398,223 | $424,800 |
| Non-Current Assets | |||||
| PPE Net | 98,871 | 103,525 | 108,176 | 111,950 | 116,567 |
| Investments And Advances | 0 | 0 | 199 | 199 | 201 |
| Intangibles | 4,355 | 4,509 | 4,621 | 4,760 | 4,977 |
| Other Non-Current Assets | 823 | 868 | 867 | 1,502 | 1,517 |
| TOTAL | $104,049 | $108,902 | $113,863 | $118,411 | $123,262 |
| Total Assets | $550,645 | $549,361 | $523,529 | $516,634 | $548,062 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,187 | 8,878 | 8,415 | 5,672 | 4,327 |
| Accrued Expenses | 64,971 | 46,885 | 47,341 | 43,190 | 49,395 |
| Other current liabilities | 1,531 | 790 | 1,162 | 1,150 | 1,588 |
| TOTAL | $97,763 | $78,609 | $76,903 | $71,052 | $77,188 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,002 | 4,304 | 4,367 | 4,909 | 4,813 |
| Other Non-Current Liabilities | 11,107 | 10,844 | 10,941 | 12,292 | 10,911 |
| TOTAL | $75,404 | $82,750 | $82,010 | $86,106 | $92,920 |
| Total Liabilities | $173,167 | $161,359 | $158,913 | $157,158 | $170,108 |
| Shareholders' Equity | |||||
| Common Shares | 1,187,696 | 1,206,613 | 1,205,554 | 1,207,982 | 1,200,218 |
| Retained earnings | -936,570 | -937,999 | -952,349 | -953,071 | -942,322 |
| Other shareholders' equity | -647 | -385 | -859 | -854 | -730 |
| TOTAL | $377,478 | $388,002 | $364,616 | $359,476 | $377,954 |
| Total Liabilities And Equity | $550,645 | $549,361 | $523,529 | $516,634 | $548,062 |